Core Viewpoint - The international dissemination of traditional Chinese medicine (TCM) must return to the essence of medicine, emphasizing its scientific and authoritative nature [1]. Group 1: Activities and Engagements - A delegation led by Li Junfeng visited Malaysia from February 22 to 25 to conduct academic exchanges and operational model assessments related to TCM [3]. - The delegation visited key locations including the Malaysian Chinese Museum, Tong Shan Hospital, and Raman University Hospital, engaging in in-depth discussions with local medical institutions and community representatives [3]. - Li Junfeng donated digital versions of "The Thirteen Classics of Traditional Chinese Medicine" and "Top Ten Famous Doctors of Chinese Medicine" to the Malaysian Chinese Museum, aiming to enhance local understanding of TCM's scientific basis [3]. Group 2: Collaboration and Insights - At Tong Shan Hospital, which has a monthly outpatient volume of 25,000, discussions were held regarding the introduction of TCM clinical techniques and talent exchange, leading to preliminary cooperation intentions [5]. - The delegation highlighted the operational model of Raman University Hospital, which integrates education, research, and community service, as having significant implications for China's current medical reform [5]. - The visit concluded with discussions in Malacca, where Li Junfeng emphasized the importance of promoting TCM internationally through professional exchanges and preserving shared cultural roots [5]. Group 3: Future Directions - The delegation plans to leverage the platform of the Beijing Chinese Medicine Association's Comprehensive Reform Working Committee to systematically summarize the operational experiences of Raman University Hospital, providing references for domestic TCM reform [5].

Group 1: Core Insights - Traditional Chinese medicine (TCM) is emphasized as a valuable heritage of Chinese civilization, with a strong push for its innovation and global promotion [1][2] - Guangdong province has implemented significant measures to promote the inheritance and innovation of TCM, aiming to establish a comprehensive reform demonstration zone for TCM [1] - The TCM industry in Guangdong is experiencing rapid growth, with the total annual output value exceeding 60 billion yuan, making it a leading region in China's TCM market [10] Group 2: TCM Practices and Innovations - In Guangdong, TCM practices are deeply integrated into daily life, with a reported 2.52 billion TCM consultations in 2024, accounting for 26.2% of total medical consultations in the province [2] - Innovative therapies such as bee therapy, which combines acupuncture and apitherapy, are gaining traction, showing significant clinical efficacy for various conditions [4] - The Guangdong Provincial Hospital of Traditional Chinese Medicine has introduced a "smart pharmacy" service, enhancing the efficiency and quality of TCM prescriptions through technology [6][7] Group 3: Talent Development and Education - The "master-apprentice" model is a key approach for cultivating TCM talent, with over 205 mentors, including 47 national TCM masters, involved in training [6] - Guangdong province is focusing on a comprehensive evaluation system for TCM practitioners, emphasizing practical abilities in diagnosis and treatment [6] Group 4: Internationalization and Market Expansion - The Guangdong-Macao Traditional Chinese Medicine Technology Industrial Park serves as a strategic hub for the internationalization of TCM, facilitating product registration and market entry in Portuguese-speaking countries [15][17] - Successful examples of TCM products entering international markets include the "Hua Tuo Rejuvenation Pill," which has gained recognition in Russia and other regions [18] Group 5: Research and Development - The Guangdong Provincial Laboratory for TCM is advancing research and development, focusing on innovative diagnostic technologies and the integration of AI in TCM practices [16] - The modern TCM industry in Guangdong is supported by a robust network of research institutions and universities, fostering collaboration and innovation [11]

Core Viewpoint - The establishment of a standard system is crucial for the internationalization of traditional Chinese medicine (TCM), providing a pathway for core products to enter overseas markets and allowing Shouxiangu (寿仙谷) to find a differentiated breakthrough in this process [1] Group 1: International Standardization Efforts - Shouxiangu has led and participated in the formulation of over 100 TCM-related standards, including 8 international standards, with 5 already published, using standardization as a tool to promote TCM's internationalization [1][2] - The company shifted its focus to international standardization after facing challenges with registering TCM as pharmaceuticals abroad, such as long approval cycles and high clinical costs [2] - The ISO international standards for Lingzhi and Dendrobium, initiated in 2011, were officially published between 2018 and 2019 and are now applied in 31 countries and regions, including the US, Canada, Australia, and Germany [2] Group 2: Key Developments in Standardization - The ISO international standard for broken-wall Lingzhi spore powder, set to be implemented by July 2025, fills a gap in global quality specifications for this product, establishing key parameters and safety limits [3] - The inclusion of Ganoderic acid A as a core quality evaluation index in the standards reflects the differentiation of raw materials and the transformation of quality characteristics into internationally recognized technical language [3] Group 3: Technological Foundation and R&D - Shouxiangu positions itself as a technology-driven enterprise, investing in all aspects of the industry chain, including breeding, cultivation, processing, and product development, to ensure product safety and effectiveness [4] - The company has developed a standardized system for the entire TCM industry chain, successfully breeding 12 new varieties of medicinal materials and obtaining multiple patents for its purification technology [4] - R&D expenses reached 9.79% of revenue in the first three quarters of 2025, an increase of 3.15 percentage points year-on-year, with the number of R&D personnel growing to 179, accounting for 16.1% of the total workforce [4] Group 4: Business Performance and Market Strategy - In the third quarter of 2025, Shouxiangu achieved revenue of 130 million yuan, a year-on-year increase of 8.51%, with online channel revenue growing by 11.80% and its share of total revenue rising from 18.97% to 23.92% [6] - The company is expanding its product line and targeting younger consumers, launching new products like Dendrobium pomelo juice and various snacks, with a focus on affordability and appealing packaging [6] - Shouxiangu is also prioritizing the cultivation of saffron, having successfully bred two new varieties with high active ingredient content, and is advancing related evidence-based medical research [6]

Core Viewpoint - The establishment of a standard system is crucial for the internationalization of traditional Chinese medicine (TCM), providing a pathway for core products to enter overseas markets and allowing Shouxiangu to find a differentiated breakthrough in the internationalization process [1] Group 1: International Standardization - Shouxiangu has led and participated in the formulation of over 100 TCM-related standards, including 8 international standards, with 5 already published [1] - The company initiated the ISO international standardization work for TCM products like Ganoderma and Dendrobium in 2011, facing initial challenges in the proposal process, which took several years to gain approval [2] - The ISO standards for Ganoderma and Dendrobium were officially published between 2018 and 2019 and are now applied in 31 countries and regions, including the US, Canada, Australia, and Germany [2] - The ISO standard for broken-wall Ganoderma spore powder, set to be implemented by July 2025, fills a global gap in quality specifications [2] Group 2: Quality Control and Research - The inclusion of Ganoderma acid A as a core quality evaluation index reflects the differentiation of raw materials and the transformation of quality characteristics into internationally recognized technical language [3] - Shouxiangu emphasizes a technology-driven approach across the entire industry chain, ensuring product safety, effectiveness, and stability through a standardized system [3] - The company has developed 12 new varieties of medicinal materials and holds multiple invention patents for its purification technology [3] Group 3: Financial Performance and R&D - In the first three quarters of 2025, Shouxiangu's R&D expense ratio reached 9.79%, an increase of 3.15 percentage points year-on-year, with R&D personnel accounting for 16.1% of the total workforce [4] - The project "Key Technology Innovation and Application of the Whole Industry Chain of Edible and Medicinal Fungi," co-led by Shouxiangu, won the National Science and Technology Progress Award [4] Group 4: Market Strategy and Product Development - In Q3 2025, Shouxiangu achieved revenue of 130 million yuan, a year-on-year increase of 8.51%, with online channel revenue growing by 11.80% [4] - The company is expanding its product line and targeting younger consumers by launching new products like "Dendrobium Pomelo Juice" and various snacks, which are positioned as everyday consumer goods [5][6] - The focus on younger demographics is evident in the design and pricing of new products, which aim to attract urban consumers seeking "light health" solutions [6]

Core Viewpoint - The article highlights the dedication of the Tianjin medical team in Congo (Brazzaville), showcasing their efforts to provide healthcare and promote traditional Chinese medicine while celebrating the Chinese New Year away from home [1][2]. Group 1: Medical Aid and Contributions - The Tianjin medical team has been active in Africa for 63 years, sending a total of 1,645 medical personnel across 59 missions [1]. - The China-Congo Friendship Hospital, established in 2013, serves as a model for Sino-African health cooperation [1]. - The first Qihuang Academy in Africa is set to open in December 2025, aimed at promoting traditional Chinese medicine globally [1]. Group 2: Cultural Exchange and Community Engagement - Local healthcare workers in Congo actively participated in Chinese New Year celebrations, demonstrating cultural exchange and appreciation [2]. - The medical team engaged in traditional activities such as making dumplings and decorating with Chinese symbols, fostering a sense of community and connection with local staff [2]. - The efforts of the Tianjin medical team not only focus on healthcare but also on building friendships and cultural ties between China and Africa [2].

Core Viewpoint - The "Global Traditional Chinese Medicine Culture Festival" successfully showcased the integration of ancient Chinese medicine with modern technology and art, emphasizing its global significance and the need for cultural exchange [1][4]. Group 1: Event Overview - The festival was co-hosted by Phoenix TV and Dong'e Ejiao, held in Beijing, and aimed to present a dialogue between civilizations through the lens of traditional Chinese medicine [1]. - The event took place on the day of the beginning of spring, symbolizing renewal and vitality, and highlighted the confidence and openness of traditional Chinese medicine on the global stage [1]. Group 2: Key Contributions and Honorees - Five individuals were honored for their outstanding contributions to the international dissemination and integration of traditional Chinese medicine [2]. - Eisen Doustmohammadi from Iran was recognized for translating the "Huangdi Neijing" into Persian and building a bridge for modern Silk Road Chinese medicine [2]. - Malaysian practitioner Liang Jiarun was acknowledged for his innovative practices in promoting traditional Chinese medicine to younger audiences [2]. - Dr. Li Zongen from the United States was celebrated for integrating AI and big data with traditional Chinese medicine, aiming to modernize its interpretation [2]. - Valeria, a disciple of Master Wang Juyi in Italy, was awarded for her dedication to practicing and spreading traditional Chinese medicine in Italy [3]. - Dr. Diallo from Mali was recognized for his efforts in training local medical personnel and providing healthcare to over 120,000 patients in Africa [3]. Group 3: Cultural Exchange and Future Initiatives - The festival featured an interactive experience area showcasing traditional Chinese medicine products and practices, enhancing public engagement [4]. - The second season of "Four Seas Traditional Chinese Medicine" was launched, aiming to document the global resonance and growth of traditional Chinese medicine [3][4]. - The event concluded with a children's choir performing a theme song co-created with AI, symbolizing the future of traditional Chinese medicine [4].

Core Viewpoint - The official release of the ISO international standard for "Broken Wall Ganoderma Spore Powder" marks a significant step in the internationalization and standardization of traditional Chinese medicine (TCM), providing a unified framework for the global industry [5][7]. Group 1: Standard Release and Significance - The ISO international standard (ISO/TS 25006:2025) for "Broken Wall Ganoderma Spore Powder" was officially released during a seminar focused on the high-quality international development of TCM [5]. - This standard establishes a comprehensive standardization system for the global broken wall Ganoderma spore powder industry, covering aspects from raw materials to production processes and quality control [7]. - The standard sets a minimum requirement of ≥95% wall-breaking rate and introduces a multi-index evaluation system for active components, ensuring both traditional practices and modern technology are integrated [7]. Group 2: Impact on Consumers and Industry - For consumers, the standard provides a more reliable product guarantee, enabling better assessment of product safety and effectiveness, and helping to distinguish genuine products from counterfeits [7]. - The company, Shouxiangu, has been a key player in TCM standardization, having led or participated in the formulation of over 100 TCM standards, including 8 international standards [7][8]. Group 3: Future Directions and Challenges - The standardization initiative is expected to drive the internationalization of TCM, with a focus on quality and safety, while also addressing the unique challenges posed by the traditional practices of TCM [9][10]. - Experts emphasize the need for a balance between standardization and the unique characteristics of TCM, advocating for a system that integrates traditional wisdom with modern scientific approaches [10][11]. - The seminar highlighted the importance of protecting authentic medicinal materials and educating international markets as key factors in promoting the internationalization of TCM [11].

Core Viewpoint - The official release of the ISO international standard for "Broken Wall Ganoderma Spore Powder" marks a significant step towards the internationalization of traditional Chinese medicine (TCM), providing a unified framework for quality and safety in the global market [4][6]. Group 1: Standard Release and Significance - The ISO standard (ISO/TS 25006:2025) for Broken Wall Ganoderma Spore Powder was officially released, establishing a comprehensive standardization system from raw materials to production and testing [4][5]. - This standard serves as a "world language" for TCM, facilitating the internationalization of Zhejiang-produced traditional medicine [4][6]. Group 2: Production and Quality Control - The standard specifies raw material sourcing requirements and sets a critical parameter of ≥95% wall-breaking rate, ensuring standardized production control [5]. - It introduces a fingerprinting multi-index evaluation system for active components, balancing traditional practices with modern technology [6]. Group 3: Consumer Impact and Industry Leadership - For consumers, the standard enhances product reliability, enabling better assessment of safety and efficacy, and helping to distinguish quality products [6]. - The company, Shouxiangu, has led the development of over 100 TCM standards, including 8 international standards, contributing to the global recognition of TCM [6][7]. Group 4: Challenges and Innovations in TCM - The implementation of the standard addresses a global quality gap in TCM and injects new momentum into the internationalization of the industry [7]. - Experts emphasize the need for a balance between traditional TCM practices and modern standardization requirements, highlighting the challenges posed by differing legal and cultural contexts [7][8]. Group 5: Future Directions - The company aims to continue its efforts in international standard formulation, promoting more Zhejiang-produced medicinal materials globally and enhancing cooperation with countries along the "Belt and Road" initiative [6][8]. - The conference signifies a new phase in TCM internationalization, focusing on standard leadership, industry collaboration, and global sharing [8].

Core Viewpoint - The establishment of the ISO international standard for "Broken Wall Ganoderma Spore Powder" marks a significant advancement in the internationalization of traditional Chinese medicine (TCM) and sets a quality benchmark for the global market [1][2]. Group 1: Standardization and Internationalization - The ISO standard (ISO/TS 25006:2025) for "Broken Wall Ganoderma Spore Powder" was officially implemented, facilitating the entry of Zhejiang-produced traditional Chinese medicine into international markets [1]. - The standard fills a global quality regulation gap in the field of Ganoderma spore powder, providing a unified measurement system for the industry [1][3]. - The standard includes specifications for raw material sources, a minimum breaking rate of 95%, and a multi-index quality control system for active components [1][2]. Group 2: Industry Growth and Economic Impact - Following the implementation of previous ISO standards for Ganoderma and Dendrobium, international trade volumes for these products increased by 284.5% and 37.5% respectively [3]. - The Zhejiang province's TCM industry is projected to achieve significant growth, with industrial output, new product output, and export scale expected to reach 5 times, 6.3 times, and 2.7 times the levels of 2005 by 2024 [3]. Group 3: Research and Development - The company has established a robust research platform, collaborating with various international institutions to enhance product technology and gather internationally recognized scientific data [2][3]. - The company has led the development of over 100 TCM standards, including 8 international standards, with several recognized by countries like the UK and Germany [2]. Group 4: Future Directions - Experts suggest that the next step for TCM is to develop a comprehensive standard system covering the entire industry chain, including cultivation, processing, quality inspection, and clinical evaluation [4]. - The company aims to continue its efforts in international standard formulation and promote more local medicinal materials globally, enhancing cooperation with countries along the Belt and Road Initiative [4].

Core Viewpoint - The release of the ISO international standard for "Broken Wall Ganoderma Spore Powder" marks a significant advancement in the standardization of traditional Chinese medicine (TCM), promoting quality and international development in the industry [1][2][4]. Group 1: Standardization and Innovation - The ISO standard (ISO/TS 25006:2025) for "Broken Wall Ganoderma Spore Powder" will be implemented in July 2025, following previous standards for other TCM products [2]. - The standard establishes key parameters such as raw material sources, a minimum 95% breaking rate, and a multi-index quality control system, enhancing production technology standardization [4]. - Experts emphasize that TCM standardization is a process of deriving scientific rules from clinical practices to form internationally recognized standards [4]. Group 2: Economic Impact - The implementation of ISO standards has led to significant increases in international trade, with related products seeing trade growth of 284.5% and 37.5% for Ganoderma and Dendrobium, respectively [5]. - The standards have been adopted in 31 countries, including major markets like the US, Canada, Australia, and Germany, facilitating trade recognition [5]. Group 3: International Collaboration - Collaborations with international institutions, such as clinical research on TCM's anti-tumor effects and cardiovascular benefits, are enhancing the scientific basis for standardization [6]. - The Zhejiang provincial government plans to strengthen the internationalization of TCM standards, focusing on local medicinal materials and specialty TCM products [6]. Group 4: Future Directions - The establishment of a comprehensive standard system covering the entire industry chain, from cultivation to clinical evaluation, is seen as essential for enhancing the industry's competitiveness [7]. - The company aims to deepen international standard formulation and promote local medicinal materials globally, particularly in countries along the Belt and Road Initiative [9].